BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33852273)

  • 41. Animal evidence considered in determination of cannabis smoke and Δ
    Iyer P; Niknam Y; Campbell M; Moran F; Kaufman F; Kim A; Sandy M; Zeise L
    Birth Defects Res; 2022 Nov; 114(18):1155-1168. PubMed ID: 36111653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects.
    Breit KR; Rodriguez CG; Lei A; Thomas JD
    Neurotoxicol Teratol; 2020; 82():106930. PubMed ID: 33086086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The psychoactive compound of Cannabis sativa, Δ(9)-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover.
    Costa MA; Fonseca BM; Marques F; Teixeira NA; Correia-da-Silva G
    Toxicology; 2015 Aug; 334():94-103. PubMed ID: 26070387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High sucrose intake during gestation increases angiotensin II type 1 receptor-mediated vascular contractility associated with epigenetic alterations in aged offspring rats.
    Wu L; Shi A; Zhu D; Bo L; Zhong Y; Wang J; Xu Z; Mao C
    Peptides; 2016 Dec; 86():133-144. PubMed ID: 27818235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.
    Hurd YL; Manzoni OJ; Pletnikov MV; Lee FS; Bhattacharyya S; Melis M
    J Neurosci; 2019 Oct; 39(42):8250-8258. PubMed ID: 31619494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Animal Models Evaluating the Impact of Prenatal Exposure to Tobacco and Marijuana.
    Olyaei AF; Campbell LR; Roberts VHJ; Lo JO
    Clin Obstet Gynecol; 2022 Jun; 65(2):334-346. PubMed ID: 35125391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study.
    Jones MJ; Lotfi A; Lin A; Gievers LL; Hendrickson R; Sheridan DC
    BMJ Open; 2022 Sep; 12(9):e061167. PubMed ID: 36171027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis during pregnancy: A way to transfer an impairment to later life.
    Motamedi S; Amleshi RS; Javar BA; Shams P; Kohlmeier KA; Shabani M
    Birth Defects Res; 2023 Sep; 115(15):1327-1344. PubMed ID: 37318343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.
    Lo JO; Hedges JC; Girardi G
    Am J Obstet Gynecol; 2022 Oct; 227(4):571-581. PubMed ID: 35662548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional imaging studies in cannabis users.
    Chang L; Chronicle EP
    Neuroscientist; 2007 Oct; 13(5):422-32. PubMed ID: 17901252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabis Use Based on Urine Drug Screens in Pregnancy and Its Association With Infant Birth Weight.
    Howard DS; Dhanraj DN; Devaiah CG; Lambers DS
    J Addict Med; 2019; 13(6):436-441. PubMed ID: 30908346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone.
    Frau R; Melis M
    J Neuroendocrinol; 2023 Feb; 35(2):e13240. PubMed ID: 36810840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An epidemiological, developmental and clinical overview of cannabis use during pregnancy.
    El Marroun H; Brown QL; Lund IO; Coleman-Cowger VH; Loree AM; Chawla D; Washio Y
    Prev Med; 2018 Nov; 116():1-5. PubMed ID: 30171964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on the developmental consequences of cannabis use during pregnancy and lactation.
    Grant KS; Conover E; Chambers CD
    Birth Defects Res; 2020 Sep; 112(15):1126-1138. PubMed ID: 32770666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are choice and self-administration of marijuana related to delta 9-THC content?
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):74-82. PubMed ID: 9234042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.
    Psychoyos D; Vinod KY
    Drug Test Anal; 2013 Jan; 5(1):27-45. PubMed ID: 22887867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.
    Levin FR; Mariani JJ; Brooks DJ; Xie S; Murray KA
    Drug Alcohol Depend; 2010 Jan; 106(1):65-8. PubMed ID: 19733018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marijuana Use for Women: To Prescribe or Not to Prescribe.
    Huang L; Zhang X; Xu A
    Subst Use Misuse; 2020; 55(12):2076-2077. PubMed ID: 32627638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.